These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 17768046)
1. Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core. Sebhat IK; Lai Y; Barakat K; Ye Z; Tang R; Kalyani RN; Vongs A; Macneil T; Weinberg DH; Cabello MA; Maroto M; Teran A; Fong TM; Van der Ploeg LH; Patchett AA; Nargund RP Bioorg Med Chem Lett; 2007 Oct; 17(20):5720-3. PubMed ID: 17768046 [TBL] [Abstract][Full Text] [Related]
2. Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists. Guo L; Ye Z; Liu J; He S; Bakshi RK; Sebhat IK; Dobbelaar PH; Hong Q; Jian T; Dellureficio JP; Tsou NN; Ball RG; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Chen HY; Chen AS; Martin WJ; MacIntyre DE; Strack AM; Fong TM; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2010 Aug; 20(16):4895-900. PubMed ID: 20621473 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of a series of cyclohexylpiperidines bearing an amide side chain as antagonists of the human melanocortin-4 receptor. Tran JA; Pontillo J; Arellano M; Fleck BA; Tucci FC; Marinkovic D; Chen CW; Saunders J; Foster AC; Chen C Bioorg Med Chem Lett; 2005 Jul; 15(14):3434-8. PubMed ID: 15950470 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of trans-4-(4-chlorophenyl)pyrrolidine-3-carboxamides of piperazinecyclohexanes as ligands for the melanocortin-4 receptor. Chen CW; Tran JA; Fleck BA; Tucci FC; Jiang W; Chen C Bioorg Med Chem Lett; 2007 Dec; 17(24):6825-31. PubMed ID: 17964151 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor. Pontillo J; Tran JA; Arellano M; Fleck BA; Huntley R; Marinkovic D; Lanier M; Nelson J; Parker J; Saunders J; Tucci FC; Jiang W; Chen CW; White NS; Foster AC; Chen C Bioorg Med Chem Lett; 2004 Sep; 14(17):4417-23. PubMed ID: 15357964 [TBL] [Abstract][Full Text] [Related]
6. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides. Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists. Tian X; Mishra RK; Switzer AG; Hu XE; Kim N; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Farmer JA; Sheldon RJ Bioorg Med Chem Lett; 2006 Sep; 16(17):4668-73. PubMed ID: 16766182 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor. Richardson TI; Ornstein PL; Briner K; Fisher MJ; Backer RT; Biggers CK; Clay MP; Emmerson PJ; Hertel LW; Hsiung HM; Husain S; Kahl SD; Lee JA; Lindstrom TD; Martinelli MJ; Mayer JP; Mullaney JT; O'Brien TP; Pawlak JM; Revell KD; Shah J; Zgombick JM; Herr RJ; Melekhov A; Sampson PB; King CH J Med Chem; 2004 Jan; 47(3):744-55. PubMed ID: 14736255 [TBL] [Abstract][Full Text] [Related]
9. Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands. Hong Q; Bakshi RK; Dellureficio J; He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Tang R; Kalyani RN; Macneil T; Vongs A; Rosenblum CI; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen D; Martin WJ; Chen AS; Metzger JM; Chen HY; Strack AM; Fong TM; Maclntyre E; Van der Ploeg LH; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2010 Aug; 20(15):4483-6. PubMed ID: 20598533 [TBL] [Abstract][Full Text] [Related]
10. Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity. He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Weinberg DH; Macneil T; Tang R; Strack AM; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Fong TM; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2010 Aug; 20(15):4399-405. PubMed ID: 20598882 [TBL] [Abstract][Full Text] [Related]
11. Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: discovery of the dihydropyridazinone motif. Ujjainwalla F; Warner D; Snedden C; Grisson RD; Walsh TF; Wyvratt MJ; Kalyani RN; Macneil T; Tang R; Weinberg DH; Van der Ploeg L; Goulet MT Bioorg Med Chem Lett; 2005 Sep; 15(18):4023-8. PubMed ID: 16005624 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators. Guo L; Ye Z; Ujjainwalla F; Sings HL; Sebhat IK; Huber J; Weinberg DH; Tang R; MacNeil T; Tamvakopoulos C; Peng Q; MacIntyre E; van der Ploeg LH; Goulet MT; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2008 Jun; 18(11):3242-7. PubMed ID: 18479920 [TBL] [Abstract][Full Text] [Related]
13. 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists. Palucki BL; Park MK; Nargund RP; Tang R; MacNeil T; Weinberg DH; Vongs A; Rosenblum CI; Doss GA; Miller RR; Stearns RA; Peng Q; Tamvakopoulos C; Van der Ploeg LH; Patchett AA Bioorg Med Chem Lett; 2005 Apr; 15(8):1993-6. PubMed ID: 15808454 [TBL] [Abstract][Full Text] [Related]
14. Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands. Bakshi RK; Hong Q; Tang R; Kalyani RN; Macneil T; Weinberg DH; Van der Ploeg LH; Patchett AA; Nargund RP Bioorg Med Chem Lett; 2006 Mar; 16(5):1130-3. PubMed ID: 16364639 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists. Wang X; Bhatia PA; Daanen JF; Latsaw SP; Rohde J; Kolasa T; Hakeem AA; Matulenko MA; Nakane M; Uchic ME; Miller LN; Chang R; Moreland RB; Brioni JD; Stewart AO Bioorg Med Chem; 2005 Aug; 13(15):4667-78. PubMed ID: 15896964 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor. Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040 [TBL] [Abstract][Full Text] [Related]
17. Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes. Conde-Frieboes K; Ankersen M; Breinholt J; Hansen BS; Raun K; Thøgersen H; Wulff BS Bioorg Med Chem Lett; 2011 Mar; 21(5):1459-63. PubMed ID: 21277204 [TBL] [Abstract][Full Text] [Related]
18. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase. Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050 [TBL] [Abstract][Full Text] [Related]
19. Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives. Grassmann S; Apelt J; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H Arch Pharm (Weinheim); 2004 Oct; 337(10):533-45. PubMed ID: 15476285 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of Tic-D-Phe Psi[CH2-CH2] isostere and its use in the development of melanocortin receptor agonists. Tian X; Chen X; Gan L; Hayes JC; Switzer AG; Solinsky MG; Ebetino FH; Wos JA; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ Bioorg Med Chem Lett; 2006 Mar; 16(6):1721-5. PubMed ID: 16376076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]